The Week in Review: November 10 – November 17, 2017

Friday, November 17, 2017 News Recap: AASLD 2017 HCV Clinical Guidelines and Patient Management highlights from The Liver Meeting 2017. Thanks to the Canadian Society for International Health we are able to share this excellent presentation, by Dr. Curtis Cooper, on highlights from AASLD 2017. Liver Cancer Global Perspectives on Hepatocellular Carcinoma.  Be sure to check out this excellent article! A panel of international oncology experts rece...

Global Perspectives On Hepatocellular Carcinoma

A panel of international oncology experts recently met to exchange thoughts on developments in the field of hepatocellular carcinoma (HCC), the most common form of liver cancer. They discussed screening and staging issues, treatment of advanced HCC and results of recent clinical trials. Treating hepatocellular carcinoma (HCC), the most common form of liver cancer, is exceptionally challenging today. Even as new therapies are on the horizon that show some

How chronic inflammation tips the balance of immune cells to promote liver cancer

Study explains success of some types of cancer immunotherapy, provides new targets for the development of additional immunotherapies Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that's because inflammation directly affects cancer cells, stimulating their division and protecting them from cell death. But University of California San Diego School of Medicine researchers have now found that chron

The Week in Review: October 13 – October 20, 2017

Friday, October 20, 2017 News Recap: Disease Management: Women: Hepatitis C in pregnancy: screening, treatment, and management. Hepatitis C (HCV) during pregnancy is associated with serious, adverse outcomes. Infants born to women with HCV are more likely to experience fetal growth restriction and low birth weight. For women, chronic HCV is associated with progressive liver damage and, during pregnancy, can be transmitted from the mother to the fe...

Obesity, hepatitis C epidemics drive ‘alarming’ increase in liver cancer incidence, mortality

There is a very good overview of liver cancer incidence and treatment in the current HemOnc Today, a part of the Healio Network. The article is long and we encourage our readers to read all of it. A SEER analysis published this summer revealed staggering statistics about liver cancer in the United States. Incidence has increased steadily since the mid-1970s, and that trend is expected to continue until at least 2030, according to the report by Islami a

The Week in Review: October 6 – October 13, 2017

Friday, October 13, 2017 News Recap: Research & Discoveries After an intense hunt, researchers at the Norwegian University of Science and Technology (NTNU) can now describe an important part of the disease's guerrilla tactics: how hepatitis C converts innocent cells into outright virus factories.  How hepatitis C hides in the body. Apparently, liver cancer can be caught at an early stage through a newly developed blood test, improving the odd...

Blood test may find liver cancer earlier, improve survival

Liver cancer can be caught at an early stage through a newly developed blood test, improving the odds for survival, according to a study led by University of California San Diego scientists. The test looks for changed gene activity, caused by a process called methylation, that indicate liver cancer, said Kang Zhang, M.D., the study’s senior author. Methylation turns genes on or off, but doesn’t affect the underlying DNA sequence. Early detection is imp

The Week in Review: September 8 – September 15, 2017

Friday, September 15, 2017 News Recap: President’s Report from HepCBC’s Annual General Meeting (AGM) HepCBC held its Annual General Meeting on September 12, 2017, and we are pleased to note that all the issues that we needed to address were covered.  Rosemary Plummer has stepped down as president after 2 GREAT YEARS of service, but the rest of the Board of Directors has been re-elected, and some very important changes to our Constitution and Bylaws ...

How liver cancer develops

An international team of researchers headed up by UZH Professor Achim Weber from the Institute of Pathology and Molecular Pathology of the University Hospital Zurich and Mathias Heikenwälder, professor at the German Cancer Research Center in Heidelberg, Germany, has discovered a major mechanism in the development of liver cancer. One of the main players in this process is enzyme caspase-8, which assumes an important dual role. Liver cancer is the second...

Overview: Innovative treatments target liver cancer

Traditional treatment for liver cancer typically involves surgery, chemotherapy and external beam radiation. However, not all patients are candidates for surgery and some may not respond to traditional chemotherapy and radiation. Today, there are several innovative approaches — such as radioembolization, chemoebolization and microwave ablation — that are making treatment more precise and more accessible to a broader number of patients. With radioemboli